Abstract
<p>Supplemental Table 1: Patient clinical and demographic characteristics. Supplemental Table 2: miRNAs differentially detected among esophageal adenocarcinoma and Barrett's esophagus. Supplemental Table 3: miRNAs differentially expressed among esophageal adenocarcinoma and Barrett's esophagus. Supplemental Table 4: miRNAs differentially expressed among esophageal adenocarcinoma and Barrett's esophagus. Supplemental Table 5: miRNAs differentially detected among early-stage (T1b & T2) esophageal adenocarcinoma and Barrett's esophagus. Supplemental Table 6: miRNAs differentially expressed among early-stage esophageal adenocarcinoma (T1b & T2) and Barrett's esophagus. Supplemental Table 7. Areas Under Receiver Operating Characteristic Curves of Pairwise miR Models Using Five-Fold Cross-Validation. Supplemental Table 8: Summary of published associations between significant top miRNAs and cancer.</p>
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
